Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05571917 · ClinicalTrials.gov registry record · NA
Healing Opioid Misuse and Pain Through Engagement (HOPE) Trial
A NA study of Chronic Pain and Opioid Use Disorder, sponsored by University of New Mexi.
- Active
- Registry status
- NA
- Development phase
- 160
- Enrollment target
- 2
- Study locations
NCT05571917 is a NA study of Chronic Pain and Opioid Use Disorder that is active but no longer recruiting, run by University of New Mexi. The registered enrollment target is 160 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (79% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT05571917, a NA study of Chronic Pain and Opioid Use Disorder, is active but no longer recruiting, sponsored by University of New Mexi.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is a multisite randomized clinical trial of a treatment designed to reduce pain interference while simultaneously addressing relapse prevention among individuals who have co-occurring chronic pain and Opioid Use Disorder (OUD). This study will recruit approximately 160 individuals who are currently being treated in clinics specializing in the physician management of OUD. To increase generalizability of study findings and increase internal validity of the physician management component of treatment, all participants will be stabilized on buprenorphine for OUD as part of their usual clinical care. Individuals will be randomized to either: (1) enhanced usual care or (2) the integrated ACT + MBRP treatment. The investigators hypothesize that: (1) the combination of ACT + MBRP in buprenorphine-prescribed patients with chronic pain will be more efficacious across primary and secondary outcome measures in comparison to Enhanced Usual Care and (2) examination of treatment mechanism data will indicate treatment-related changes that are consistent with the theoretical models of ACT+MBRP.
Conditions Studied
Interventions
- BEHAVIORAL Acceptance and Commitment Therapy + Mindfulness Based Relapse Prevention (ACT + MBRP)
- BEHAVIORAL Enhance Usual Care (EUC)
Study Locations (2)
Michigan
- University of Michigan - Ann Arbor
New Mexico
- University of New Mexico - Albuquerque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2023-05-05 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05571917
The ClinicalTrials.gov registry entry for NCT05571917 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (79% lower). The listed sponsor is University of New Mexi, which has 76 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Acceptance and Commitment Therapy + Mindfulness Based Relapse Prevention (ACT + MBRP) is the first listed.
NCT05571917 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Michigan, New Mexico.
Frequently Asked Questions
What is clinical trial NCT05571917 about?
NCT05571917 is a clinical study titled "Healing Opioid Misuse and Pain Through Engagement (HOPE) Trial". This study is a multisite randomized clinical trial of a treatment designed to reduce pain interference while simultaneously addressing relapse prevention among individuals who have co-occurring chronic pain and Opioid Use Disorder (OUD). This study will recruit approximately 160 individuals who are...
What is the current status of trial NCT05571917?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2023-05-05. Estimated completion is 2026-12-31.
What conditions does trial NCT05571917 study?
This clinical trial studies the following conditions: Chronic Pain, Opioid Use Disorder.
What interventions are being tested in trial NCT05571917?
The interventions under investigation include: Acceptance and Commitment Therapy + Mindfulness Based Relapse Prevention (ACT + MBRP) (BEHAVIORAL), Enhance Usual Care (EUC) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05571917?
This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05571917 being conducted?
This trial has 2 study locations across Michigan, New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.